#Vaccineresearch

A shift in U.S. health policy under the current administration raises questions about the future of mRNA research. Health and Human Services leadership signals potential changes in funding that could affect ongoing projects, including studies on mRNA vaccines and immune responses. Once celebrated for accelerating vaccine development during the COVID-19 era, mRNA technology now faces renewed scrutiny. For Thai readers, the implications extend beyond one country, touching global science, public health strategy, and regional collaboration.